Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Chronic rhinosinusitis (CRS) including nasal polyps is a chronic inflammatory disease involving the mucosa of the nose and one or more paranasal sinuses. Despite differing hypotheses, the cause ...

to evaluate the interaction between the parasympathetic limb of the autonomous nervous system and the sinus node cells during long-term lithium treatment. PATIENTS AND METHODS--45 patients who had ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

This makes it difficult to identify skin diseases by images alone. The causes and treatments for these skin diseases vary. It's important to consult a healthcare provider, such as a dermatologist ...

Computed tomography and magnetic resonance imaging of paranasal sinuses (Fig. 1 ... should lead to an early biopsy due to the rapid course of this type of lymphoma, with prompt treatment performed by ...

are treated in order to prevent a disease from occurring. Treatment normally begins either before signs and symptoms of the disease occur, or shortly thereafter. Treatment can include patient ...

Points to New Treatments Nov. 26, 2024 — Scientists used a new video-based machine learning tool to pinpoint otherwise-undetectable signs of early disease in mice that were engineered to mimic ...

Radiological evaluation of the head, neck, paranasal sinuses and chest were unremarkable ... They should not be used in isolation to guide treatment choices or public health policy. Competing ...

“Because asthma is a highly variable disease with different endotypes, which are driven by different immune cells and respond differently to treatments, the first step toward better therapies is ...